"Das Department für Frauengesundheit (Universitäts-Frauenklinik und Forschungsinstitut für Frauengesundheit) befasst sich mit der Erforschung, Erkennung, Vorbeugung und Heilung von spezifischen Erkrankungen von Frauen und betreibt eine umfangreiche Versorgung rund um das Gebiet von Schwangerschaft und Geburt und den gynäkologischen Erkrankungen. Es gehört zu den führenden Einrichtungen in Deutschland. Mit dem integrierten Forschungsinstitut für Frauengesundheit wird dieser umfassende Ansatz strukturell und inhaltlich noch zusätzlich ergänzt."

During the past decade, University Hospital Tuebingen, Department of Women's Health conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Tuebingen, Department of Women's Health" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Department of Gynecology and Obstetrics, University Hospital Erlangen, Germany" with 1 trials as a collaborator, "Department of Gynecology and Obstetrics, University Hospital Heidelberg, Germany" with 1 trials as a collaborator, "Institute of Occupational and Social Medicine and Health Services Research, Tuebingen" with 1 trials as a collaborator and "National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Germany" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Tuebingen, Department of Women's Health" are "Breast Cancer Female" (2 trials), "Breast Cancer Surgery" (2 trials), "Pregnancy" (2 trials), "Advanced Inoperable Vulva Carcinoma" (1 trials) and "Breast Biopsy" (1 trials). Many other conditions were trialed in "University Hospital Tuebingen, Department of Women's Health" in a lesser frequency.

Most popular intervention types in "University Hospital Tuebingen, Department of Women's Health" are "Procedure" (6 trials), "Device" (3 trials), "Diagnostic Test" (3 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "laparoscopic surgery" (2 trials), "Betamethason Sodium Phosphate" (1 trials), "CAP treatment" (1 trials), "Conventional breast surgery" (1 trials) and "Electrochemotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Tuebingen, Department of Women's Health" are 15 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "University Hospital Tuebingen, Department of Women's Health". undefined are not yet recruiting, 8 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in University Hospital Tuebingen, Department of Women's Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Tuebingen, Department of Women's Health, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".